Literature DB >> 28870997

The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2.

Claire M Pfeffer1, Benjamin N Ho1, Amareshwar T K Singh2.   

Abstract

BRCA1 and BRCA2 are both tumor suppressors whose mutations are the cause of most hereditary breast cancers. Both genes are highly involved in ensuring genome stability. BRCA1 homologs are found in the plant and animal kingdoms while BRCA2 homologs are additionally found in the fungi kingdom. The initial origin of both genes remains unknown, however it is expected that the common ancestors originated around 1.6 billion years ago prior to the kingdoms diverging. There has been a great amount of divergence between homologs that is not observed in other tumor suppressors with only functionally important domains conserved. This divergence continues today with evidence of primate BRCA1/2 evolution. Cancer-associated mutations have been found to occur at conserved sites, indicating that conserved sites are important for function. In this study, we present a review on the phylogenesis of BRCA1 and BRCA2. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  BRCA1; BRCA2; breast cancer; phylogenesis; review

Mesh:

Substances:

Year:  2017        PMID: 28870997      PMCID: PMC5611516          DOI: 10.21873/cgp.20040

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  25 in total

1.  BRCA2 is a mediator of RAD51- and DMC1-facilitated homologous recombination in Arabidopsis thaliana.

Authors:  Katharina Seeliger; Stefanie Dukowic-Schulze; Rebecca Wurz-Wildersinn; Michael Pacher; Holger Puchta
Journal:  New Phytol       Date:  2011-11-11       Impact factor: 10.151

2.  Interaction between Arabidopsis Brca2 and its partners Rad51, Dmc1, and Dss1.

Authors:  Eloïse Dray; Nicolas Siaud; Emeline Dubois; Marie-Pascale Doutriaux
Journal:  Plant Physiol       Date:  2006-01-13       Impact factor: 8.340

Review 3.  Homologous repair of DNA damage and tumorigenesis: the BRCA connection.

Authors:  Maria Jasin
Journal:  Oncogene       Date:  2002-12-16       Impact factor: 9.867

Review 4.  Therapeutic targeting and patient selection for cancers with homologous recombination defects.

Authors:  Francien Talens; Mathilde Jalving; Jourik A Gietema; Marcel A Van Vugt
Journal:  Expert Opin Drug Discov       Date:  2017-05-02       Impact factor: 6.098

5.  BRCA2 homolog required for proficiency in DNA repair, recombination, and genome stability in Ustilago maydis.

Authors:  Milorad Kojic; Corwin F Kostrub; Andrew R Buchman; William K Holloman
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

6.  Dual DNA-binding domains shape the interaction of Brh2 with DNA.

Authors:  Qingwen Zhou; William K Holloman
Journal:  DNA Repair (Amst)       Date:  2014-08-13

7.  Ancient and recent adaptive evolution of primate non-homologous end joining genes.

Authors:  Ann Demogines; Alysia M East; Ji-Hoon Lee; Sharon R Grossman; Pardis C Sabeti; Tanya T Paull; Sara L Sawyer
Journal:  PLoS Genet       Date:  2010-10-21       Impact factor: 5.917

8.  Decreased miR-206 expression in BRCA1 wild-type triple-negative breast cancer cells after concomitant treatment with gemcitabine and a Poly(ADP-ribose) polymerase-1 inhibitor.

Authors:  Akiko Sasaki; Yuko Tsunoda; Mayumi Tsuji; Yuko Udaka; Hideto Oyamada; Hiromichi Tsuchiya; Katsuji Oguchi
Journal:  Anticancer Res       Date:  2014-09       Impact factor: 2.480

9.  A strategy to apply quantitative epistasis analysis on developmental traits.

Authors:  Marta K Labocha; Wang Yuan; Boanerges Aleman-Meza; Weiwei Zhong
Journal:  BMC Genet       Date:  2017-05-15       Impact factor: 2.797

Review 10.  BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?

Authors:  Li Wang; Li-Jun Di
Journal:  Int J Biol Sci       Date:  2014-05-14       Impact factor: 6.580

View more
  11 in total

1.  The Role of Circulating Adiponectin and SNP276G>T at ADIPOQ Gene in BRCA-mutant Women.

Authors:  Antonella Daniele; Angelo Virgilio Paradiso; Rosa Divella; Maria Digennaro; Margherita Patruno; Stefania Tommasi; Brunella Pilato; Antonio Tufaro; Michele Barone; Carla Minoia; Donatella Colangelo; Eufemia Savino; Porzia Casamassima; Eleonora Bruno; Andreina Oliverio; Patrizia Pasanisi
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

2.  A Phylogenetic Approach to Analyze the Conservativeness of BRCA1 and BRCA2 Mutations.

Authors:  Jiaying Lai; Indra Neil Sarkar
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

3.  Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods.

Authors:  Hongye Hu; Buran Chen; Danni Zheng; Guanli Huang
Journal:  PeerJ       Date:  2020-05-25       Impact factor: 2.984

4.  Identifying a BRCA2 c.5722_5723del mutation in a Han-Chinese family with breast cancer.

Authors:  Yi Guo; Peng Wang; Xiaorong Li; Shaihong Zhu; Hongbo Xu; Shizhou Li; Hao Deng; Lamei Yuan
Journal:  Biosci Rep       Date:  2019-04-30       Impact factor: 3.840

5.  The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability.

Authors:  Adalgeir Arason; Bjarni A Agnarsson; Gudrun Johannesdottir; Oskar Th Johannsson; Bylgja Hilmarsdottir; Inga Reynisdottir; Rosa B Barkardottir
Journal:  Genes (Basel)       Date:  2019-11-01       Impact factor: 4.096

Review 6.  Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets.

Authors:  Can-Bin Fang; Hua-Tao Wu; Man-Li Zhang; Jing Liu; Guo-Jun Zhang
Journal:  Front Cell Dev Biol       Date:  2020-04-02

7.  A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy.

Authors:  Yinglian Pan; Li Ping Jia; Yuzhu Liu; Yiyu Han; Qian Li; Qin Zou; Zhongpei Zhang; Jin Huang; Qingchun Deng
Journal:  J Ovarian Res       Date:  2020-09-19       Impact factor: 4.234

Review 8.  Single-Strand Annealing in Cancer.

Authors:  Janusz Blasiak
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

Review 9.  Homologous Recombination Deficiencies and Hereditary Tumors.

Authors:  Hideki Yamamoto; Akira Hirasawa
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

10.  Human BRCA pathogenic variants were originated during recent human history.

Authors:  Jiaheng Li; Bojin Zhao; Teng Huang; Zixin Qin; San Ming Wang
Journal:  Life Sci Alliance       Date:  2022-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.